Maryland 2022 Regular Session

Maryland Senate Bill SB661

Introduced
2/4/22  
Refer
2/4/22  
Report Pass
3/18/22  
Engrossed
3/21/22  
Refer
3/21/22  
Report Pass
4/7/22  
Enrolled
4/11/22  
Chaptered
5/16/22  

Caption

Pharmacists - Status as Health Care Providers and Study on Reimbursement

Impact

The legislation mandates that insurers and health service plans reimburse pharmacists for health care services at rates equivalent to those paid for similar services provided by other health care professionals. This change aims to enhance access to health care by enabling pharmacists to offer care directly, which is particularly beneficial in rural and underserved areas. By positioning pharmacists as integral components of the health care system, the bill seeks to alleviate burdens on other health care providers and improve patient access to health care services.

Summary

Senate Bill 661 establishes pharmacists as recognized health care providers in Maryland, allowing them to receive reimbursements for providing health care services. This bill significantly expands the role of pharmacists beyond traditional medication dispensing, enabling them to participate in broader health care activities, including administering certain health care services and engaging in health care malpractice claims. The inclusion of pharmacists under the definition of health care providers aligns their professional contributions with those of physicians, physician assistants, and nurse practitioners.

Sentiment

The general sentiment surrounding SB 661 appears to be favorable among pharmacy practitioners and many health advocates, who argue that this legislation is a necessary step to fully utilize the existing capacity of pharmacists in addressing public health needs. Supporters believe that the expanded role will not only provide pharmacists with needed financial recognition but also improve patient care outcomes. However, concern has been expressed by some traditional healthcare providers about the adequacy of training and oversight for pharmacists as they take on these expanded roles.

Contention

Notable points of contention regarding SB 661 include debates about the sufficiency of training that pharmacists receive to handle additional health care responsibilities, as well as the potential impact on physician-patient relationships. Some critics worry that the introduction of pharmacists in roles traditionally held by medical doctors could lead to fragmentation in patient care. The bill also sparked discussions about insurance companies’ willingness to adapt to these changes and the operational adjustments necessary for effective reimbursement practices.

Companion Bills

No companion bills found.

Similar Bills

MD HB693

State Board of Pharmacy - Board Membership, Delegated Pharmacy Acts, and Sunset Extension

MD HB171

State Board of Pharmacy - Membership - Veterinary Pharmacist

MD HB1219

Pharmacists - Status as Health Care Providers and Study on Reimbursement

MD SB647

State Board of Pharmacy - Board Membership, Delegated Pharmacy Acts, and Sunset Extension

MD HB229

Pharmacists - Administration of Injectable Medications for Treatment of Sexually Transmitted Infections

MD SB19

Pharmacists - Administration of Injectable Medications for Treatment of Sexually Transmitted Infections

MD HB1278

Pharmacists - Status as Health Care Providers and Reimbursement

MD HB1151

Health Insurance - Reimbursement for Services Rendered by a Pharmacist